Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Fate Therapeutics (FATE)

Fate Therapeutics (FATE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fate Therapeutics 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 USA

P: 858-875-1800

Description:

Fate Therapeutics, Inc. is a biopharmaceutical company. The company focused on the discovery and development of adult stem cell modulators to treat hematologic malignancies, lysosomal storage disorders and muscular dystrophies. Fate Therapeutics, Inc. is headquartered in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 2,191,691
Shares Outstanding, K 77,692
Annual Sales, $ 10,680 K
Annual Net Income, $ -98,150 K
Last Quarter Sales, $ 2,520 K
Last Quarter Net Income, $ -33,520 K
60-Month Beta 1.77
% of Insider Shareholders 21.41%
% of Institutional Shareholders 97.33%
Float, K 61,058
% Float 78.59%

Growth:

1-Year Return 48.01%
3-Year Return 784.33%
5-Year Return 363.22%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -15.20%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.44 on 05/11/20
Next Earnings Date N/A
Earnings Per Share ttm -1.57
EPS Growth vs. Prev Qtr -18.92%
EPS Growth vs. Prev Year -46.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

FATE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -13.81
Price/Earnings to Growth N/A
Return-on-Equity % -52.08%
Return-on-Assets % -38.45%
Profit Margin % -919.01
Net Margin % N/A
Debt/Equity 0.10
Price/Sales 218.53
Price/Cash Flow N/A
Price/Book 10.41
Book Value/Share 2.89
Interest Coverage -55.09
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar